Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-16
DOI
10.3389/fimmu.2021.786617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase
- (2021) Ericka Kirkpatrick Roubidoux et al. mSphere
- An Update on Self-Amplifying mRNA Vaccine Development
- (2021) Anna K. Blakney et al. Vaccines
- Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics
- (2021) Meiling Dai et al. mBio
- Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone
- (2021) Jin Gao et al. PLoS Pathogens
- Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice
- (2021) Shirin Strohmeier et al. Vaccines
- Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
- (2021) Brianna L. Bullard et al. Vaccines
- Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains
- (2021) Amanda L. Skarlupka et al. JOURNAL OF VIROLOGY
- Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses
- (2021) Bryan S. Kaplan et al. JOURNAL OF VIROLOGY
- Epitope-targeting platform for broadly protective influenza vaccines
- (2021) David F. Zeigler et al. PLoS One
- Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
- (2021) Alec W. Freyn et al. Molecular Therapy-Methods & Clinical Development
- Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model
- (2021) Jessica Tan et al. JOURNAL OF VIROLOGY
- Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model
- (2021) Zach Menne et al. VIROLOGY
- Tetrameric Neuraminidase of Influenza A Virus Is Required to Induce Protective Antibody Responses in Mice
- (2021) Xiren Deng et al. Frontiers in Microbiology
- Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
- (2020) Fei-Fei Xiong et al. Emerging Microbes & Infections
- A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
- (2020) Alec W. Freyn et al. MOLECULAR THERAPY
- Structural transitions in influenza haemagglutinin at membrane fusion pH
- (2020) Donald J. Benton et al. NATURE
- Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic
- (2020) Hiroko Ito et al. PLoS One
- Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals
- (2020) Allen Zheng et al. JOURNAL OF VIROLOGY
- N-linked glycan sites on the influenza NA head domain are required for efficient IAV incorporation and replication
- (2020) Henrik Östbye et al. JOURNAL OF VIROLOGY
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
- (2020) George Ueda et al. eLife
- Self-amplifying RNA vaccines for infectious diseases
- (2020) Kristie Bloom et al. GENE THERAPY
- Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective
- (2020) Anders Madsen et al. IMMUNITY
- Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice
- (2020) Meagan McMahon et al. VACCINE
- Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus
- (2020) Haihai Jiang et al. mBio
- Second sialic acid‐binding site of influenza A virus neuraminidase: binding receptors for efficient release
- (2020) Wenjuan Du et al. FEBS Journal
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk
- (2019) Victor A. Streltsov et al. Acta Crystallographica Section F-Structural Biology Communications
- Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus
- (2019) Atsuhiro Yasuhara et al. Nature Microbiology
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
- (2019) Masaru Kanekiyo et al. NATURE IMMUNOLOGY
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- Influenza Hemagglutinin and Neuraminidase: Yin–Yang Proteins Coevolving to Thwart Immunity
- (2019) Ivan Kosik et al. Viruses-Basel
- Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
- (2019) Jin Gao et al. mBio
- Influenza A virus surface proteins are organized to help penetrate host mucus
- (2019) Michael D Vahey et al. eLife
- The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance
- (2019) Wenjuan Du et al. PLoS Pathogens
- Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
- (2019) Bárbara Sucena Rodrigues et al. HEART
- Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase
- (2019) Felix Broecker et al. JOURNAL OF VIROLOGY
- Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
- (2019) Ki-Hye Kim et al. VIROLOGY
- Deleterious Effects of Neonicotinoid Pesticides on Drosophila melanogaster Immune Pathways
- (2019) John A. Chmiel et al. mBio
- Structural restrictions for influenza neuraminidase activity promote adaptation and diversification
- (2019) Hao Wang et al. Nature Microbiology
- Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
- (2019) Pramila Rijal et al. JOURNAL OF VIROLOGY
- Broadly protective human antibodies that target the active site of influenza virus neuraminidase
- (2019) Daniel Stadlbauer et al. SCIENCE
- Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
- (2019) Iuliia M. Gilchuk et al. Cell Host & Microbe
- Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies
- (2019) Xueyong Zhu et al. Cell Host & Microbe
- Influenza A Virus Hemagglutinin–Neuraminidase–Receptor Balance: Preserving Virus Motility
- (2019) Erik de Vries et al. TRENDS IN MICROBIOLOGY
- Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice
- (2019) Ye Wang et al. Advanced Healthcare Materials
- Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
- (2018) Yao-Qing Chen et al. CELL
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors
- (2018) Boyu Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses
- (2018) Jing Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus
- (2018) Zhu Guo et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces
- (2018) Hongbo Guo et al. PLoS Pathogens
- New Vaccine Technologies to Combat Outbreak Situations
- (2018) Susanne Rauch et al. Frontiers in Immunology
- Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
- (2018) E. R. Job et al. npj Vaccines
- Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza
- (2017) E.R. Job et al. JOURNAL OF VIROLOGY
- Comparison of the Efficacy of N9 Neuraminidase-specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection
- (2017) Hongquan Wan et al. JOURNAL OF VIROLOGY
- Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge
- (2017) Alaina J. Mooney et al. JOURNAL OF VIROLOGY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets
- (2017) Gale E. Smith et al. VIROLOGY
- Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
- (2017) Sinthujan Jegaskanda et al. Human Vaccines & Immunotherapeutics
- Complete mapping of viral escape from neutralizing antibodies
- (2017) Michael B. Doud et al. PLoS Pathogens
- Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
- (2017) Teddy John Wohlbold et al. Nature Microbiology
- Predicting evolution
- (2017) Michael Lässig et al. Nature Ecology & Evolution
- Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses
- (2017) Sehee Park et al. Scientific Reports
- An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo
- (2016) Jason R. Wilson et al. ANTIVIRAL RESEARCH
- Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
- (2016) Carole J. Henry Dunand et al. Cell Host & Microbe
- Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
- (2016) David J. DiLillo et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins
- (2016) Meiling Dai et al. JOURNAL OF VIROLOGY
- Identification of amino acids in H9N2 influenza virus neuraminidase that are critical for the binding of two mouse monoclonal antibodies
- (2016) Zhimin Wan et al. VETERINARY MICROBIOLOGY
- Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
- (2016) Matthew J. Memoli et al. mBio
- Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies
- (2016) Michael Schotsaert et al. Scientific Reports
- Viral Receptor-Binding Site Antibodies with Diverse Germline Origins
- (2015) Aaron G. Schmidt et al. CELL
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
- (2015) Arnold S. Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination
- (2015) Joshua G. Petrie et al. JOURNAL OF INFECTIOUS DISEASES
- Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase
- (2015) Lianlian Jiang et al. JOURNAL OF VIROLOGY
- Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses
- (2015) Wen-Chun Liu et al. JOURNAL OF VIROLOGY
- Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses
- (2015) Jaina M. Patel et al. Nanomedicine-Nanotechnology Biology and Medicine
- Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge
- (2015) Brock Kingstad-Bakke et al. VACCINE
- Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
- (2015) Hongquan Wan et al. Nature Communications
- H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
- (2015) Hang Xie et al. Scientific Reports
- Conserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza Viruses
- (2014) Y. Iba et al. JOURNAL OF VIROLOGY
- Structure of Influenza Virus N7: the Last Piece of the Neuraminidase "Jigsaw" Puzzle
- (2014) X. Sun et al. JOURNAL OF VIROLOGY
- Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge
- (2014) F. M. Cardoso et al. JOURNAL OF VIROLOGY
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season
- (2014) S. L. Linderman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stability of neuraminidase in inactivated influenza vaccines
- (2014) Ishrat Sultana et al. VACCINE
- Conserved and host-specific features of influenza virion architecture
- (2014) Edward C. Hutchinson et al. Nature Communications
- Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus
- (2014) Peter S. Lee et al. Nature Communications
- Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
- (2013) Tracey M. Doyle et al. ANTIVIRAL RESEARCH
- A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains
- (2013) Tracey M. Doyle et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Polar Residues and Their Positional Context Dictate the Transmembrane Domain Interactions of Influenza A Neuraminidases
- (2013) Johan Nordholm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
- (2013) Robert B. Couch et al. JOURNAL OF INFECTIOUS DISEASES
- Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
- (2013) H. Wan et al. JOURNAL OF VIROLOGY
- Functional and Structural Analysis of Influenza Virus Neuraminidase N3 Offers Further Insight into the Mechanisms of Oseltamivir Resistance
- (2013) Q. Li et al. JOURNAL OF VIROLOGY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins
- (2013) N. S. Heaton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
- (2013) B. F. Koel et al. SCIENCE
- Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
- (2013) Miriam Cohen et al. Virology Journal
- Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding
- (2013) Yan Wu et al. Scientific Reports
- Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines
- (2012) Melkamu Getie-Kebtie et al. Influenza and Other Respiratory Viruses
- Assembly of Subtype 1 Influenza Neuraminidase Is Driven by Both the Transmembrane and Head Domains
- (2012) Diogo V. da Silva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Theoretical Studies on the Susceptibility of Oseltamivir against Variants of 2009 A/H1N1 Influenza Neuraminidase
- (2012) Lin Li et al. Journal of Chemical Information and Modeling
- Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution
- (2012) K. B. Westgeest et al. JOURNAL OF GENERAL VIROLOGY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus
- (2012) Chia-Ying Wu et al. PLoS One
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
- (2012) G.-M. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines
- (2012) Robert B. Couch et al. VACCINE
- Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
- (2012) Judith D. Easterbrook et al. VIROLOGY
- Coexpression of Avian Influenza Virus H5 and N1 by Recombinant Newcastle Disease Virus and the Impact on Immune Response in Chickens
- (2011) Kristina Ramp et al. AVIAN DISEASES
- Influenza neuraminidase
- (2011) Gillian M. Air Influenza and Other Respiratory Viruses
- Influenza A Virus N5 Neuraminidase Has an Extended 150-Cavity
- (2011) M. Wang et al. JOURNAL OF VIROLOGY
- The Genomic Rate of Molecular Adaptation of the Human Influenza A Virus
- (2011) Samir Bhatt et al. MOLECULAR BIOLOGY AND EVOLUTION
- Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses
- (2011) Jinling Li et al. PLoS One
- A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase
- (2011) Peter M. Schmidt et al. PLoS One
- Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance
- (2011) Scott E. Hensley et al. PLoS One
- Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
- (2011) M. R. Sandbulte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir
- (2011) Ishrat Sultana et al. VACCINE
- Influenza virus assembly and budding
- (2011) Jeremy S. Rossman et al. VIROLOGY
- Mechanism of 150-cavity formation in influenza neuraminidase
- (2011) Rommie E. Amaro et al. Nature Communications
- Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase
- (2010) J. C. C. Lai et al. JOURNAL OF GENERAL VIROLOGY
- Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
- (2010) B. J. Bosch et al. JOURNAL OF VIROLOGY
- Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
- (2010) Lea Torrieri-Dramard et al. MOLECULAR THERAPY
- A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
- (2010) Annett Hessel et al. PLoS One
- Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses
- (2009) Jennifer Uhlendorff et al. ARCHIVES OF VIROLOGY
- Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs
- (2009) Z. Chen et al. JOURNAL OF VIROLOGY
- Contributions of the Avian Influenza Virus HA, NA, and M2 Surface Proteins to the Induction of Neutralizing Antibodies and Protective Immunity
- (2009) B. Nayak et al. JOURNAL OF VIROLOGY
- A Genetically Engineered Waterfowl Influenza Virus with a Deletion in the Stalk of the Neuraminidase Has Increased Virulence for Chickens
- (2009) S. Munier et al. JOURNAL OF VIROLOGY
- The Special Neuraminidase Stalk-Motif Responsible for Increased Virulence and Pathogenesis of H5N1 Influenza A Virus
- (2009) Hongbo Zhou et al. PLoS One
- Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)
- (2009) Bin Su et al. PLoS One
- Virus-Like Particle Vaccine Comprised of the HA, NA, and M1 Proteins of an Avian Isolated H5N1 Influenza Virus Induces Protective Immunity Against Homologous and Heterologous Strains in Mice
- (2009) Pan Tao et al. VIRAL IMMUNOLOGY
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season
- (2008) Edward A. Belongia et al. JOURNAL OF INFECTIOUS DISEASES
- Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
- (2008) X. Xu et al. JOURNAL OF VIROLOGY
- Evidence of Expanded Host Range and Mammalian-Associated Genetic Changes in a Duck H9N2 Influenza Virus Following Adaptation in Quail and Chickens
- (2008) Md Jaber Hossain et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More